ID: ALA4064999

Max Phase: Preclinical

Molecular Formula: C50H73N5O8

Molecular Weight: 872.16

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H]1C(=O)N2CCC[C@H]2C(=O)O[C@H](C(C)(C)C)C[C@@H](C)C[C@H](O)[C@H](C)C(=O)N2CCC(CC2)C(=O)N[C@@H](Cc2ccc(-c3ccccc3)cc2)C(=O)N(C)[C@@H](C)C(=O)N1C

Standard InChI:  InChI=1S/C50H73N5O8/c1-11-32(3)43-48(61)55-25-15-18-40(55)49(62)63-42(50(6,7)8)29-31(2)28-41(56)33(4)45(58)54-26-23-38(24-27-54)44(57)51-39(47(60)52(9)34(5)46(59)53(43)10)30-35-19-21-37(22-20-35)36-16-13-12-14-17-36/h12-14,16-17,19-22,31-34,38-43,56H,11,15,18,23-30H2,1-10H3,(H,51,57)/t31-,32-,33-,34-,39-,40-,41-,42-,43-/m0/s1

Standard InChI Key:  PXUDINJTRSVEDH-ONEVUBGOSA-N

Associated Targets(Human)

U-87 MG 3946 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MKN-74 303 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Huh-7 12904 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SK-OV-3 52876 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

786-0 47912 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

BXPC-3 2997 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver 3974 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver 8163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 872.16Molecular Weight (Monoisotopic): 871.5459AlogP: 5.72#Rotatable Bonds: 5
Polar Surface Area: 156.87Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.62CX Basic pKa: CX LogP: 5.69CX LogD: 5.69
Aromatic Rings: 2Heavy Atoms: 63QED Weighted: 0.29Np Likeness Score: 0.94

References

1. Onda Y, Masuda Y, Yoshida M, Doi T..  (2017)  Conformation-Based Design and Synthesis of Apratoxin A Mimetics Modified at the α,β-Unsaturated Thiazoline Moiety.,  60  (15): [PMID:28682609] [10.1021/acs.jmedchem.7b00833]

Source